Abstract
Objective
The aim of this study was to investigate whether milk fortified with folic acid enhances the folate status of humans and whether the presence of folate-binding proteins (FBP) in pasteurised milk affects the bioavailability of folic acid from fortified milk. In untreated and pasteurised milk, folate occurs bound to FBP, while FBP is (partly) denatured in ultra-high-temperature (UHT)-treated milk. The effect of FBP on folate bioavailability is still unclear.
Design, subjects and setting
Healthy, free-living subjects (n=69) aged 18–49 y participated in a 4-week double-blind, placebo-controlled dietary intervention study.
Intervention
In addition to a fully controlled diet, the subjects consumed each day 500 ml of pasteurised or UHT milk, either fortified or not with 200 μg folic acid.
Results
Consumption of fortified milk increased folate concentrations in serum and in red blood cells (RBC) by 6.6–7.0 nmol/l (P<0.001) and 32–36 nmol/l (P<0.01), respectively. Similarly, plasma homocysteine concentrations were lowered 0.88–0.89 μmol/l (P=0.001) in subjects who consumed fortified milk. The bioavailability of folic acid from pasteurised milk relative to that of folic acid from UHT milk was 74–94% (NS), depending on the parameter used.
Conclusions
Milk fortified to supply an additional 200 μg of folic acid/s substantially increased folate status, and decreased plasma total homocysteine concentrations in young, healthy subjects. Milk is therefore a suitable matrix for fortification to enhance the folate status in humans. No significant effect of endogenous FBP was found on the bioavailability of folic acid from milk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
AOAC International, ed: AOAC Official method 992.16 (1996): Official Methods of Analysis of AOAC International Vol. II, 16th Edition. Arlingtonm, VA: Association of Official Analytical Chemists International.
AOAC International, ed: AOAC Official Method 920.85 (1999): Official Methods of Analysis of AOAC International Vol. II, 16th Editon, Arlington, VA: Association of Official Analytical Chemists International.
Boushey CJ, Beresford SAA, Omenn GS & Motulsky AG (1995): A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274, 1049–1057.
Brouwer IA, van Dusseldorp M, Thomas CMG, Duran M, Hautvast JGAJ, Eskes TKAB & Steegers-Theunissen RPM (1999b): Low-dose folic acid supplementation decreases plasma homocysteine: a randomized trial. Am. J. Clin. Nutr. 69, 99–104.
Brouwer IA, van Dusseldorp M, West CE, Meyboom S, Thomas CMG, Duran M, van het Hof KH, Eskes TKAB, Hautvast JGAJ & Steegers-Theunissen RPM (1999a): Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J. Nutr. 129, 1135–1139.
Castenmiller JJM, van de Poll CJ, West CE, Brouwer IA, Thomas CM & van Dusseldorp M (2000): Bioavailability of folate from processed spinach in humans. Effect of food matrix and interaction with carotenoids. Ann. Nutr. Metab. 44, 163–169.
Colman N, Hettiarachchy N & Herbert V (1981): Detection of a milk factor that facilitates folate uptake by intestinal cells. Science 211, 1427–1429.
Daly S, Mills JL, Molloy AM, Conley M, Lee YL, Kirke PN, Weir DG & Scott JM (1997): Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 350, 1666–1669.
De Bree A, van Dusseldorp M, Brouwer IA, van het Hof KH & Steegers-Theunissen RPM (1997): Folate intake in Europe: recommended, actual and desired intake. Eur. J. Clin. Nutr. 51, 643–660.
Feunekes GIJ, van Staveren WA, de Vries JHM, Burema J & Hautvast JGAJ (1993): Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am. J. Clin. Nutr. 58, 489–496.
Fishman SM, Christian P & West KP (2000): The role of vitamins in the prevention and control of anaemia. Public Health Nutr. 3, 125–150.
Fohr IP, Prinz-Langenohl R, Brönstrup A, Bohlmann AM, Nau H, Berthold HK & Pietrzik K (2002): 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am. J. Clin. Nutr. 75, 275–282.
Ford JE (1974): Some observations on the possible nutritional significance of vitamin B12- and folate-binding proteins in milk. Br. J. Nutr. 31, 243–257.
Forssén KM, Jägerstad MI, Wigertz K & Witthöft CM (2000): Folates and dairy products: a critical update. J. Am. Coll. Nutr. 19, 100S–110S.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP & Rozen R (1995): A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10, 111–113.
Ghitis J (1967): The folate binding in milk. Am. J. Clin. Nutr. 20, 1–4.
Glynn SA & Albanes D (1994): Folate and cancer: a review of the literature. Nutr. Cancer. 22, 101–119.
Gregory JF (1982): Denaturation of the folacin-binding protein in pasteurized milk products. J. Nutr. 112, 1329–1338.
Høier-Madsen M, Hansen SI & Holm J (1986): Rabbit antibodies against the folate binding protein from cow's milk. Production, characterisation and use for development of an enzyme-linked immunosorbent assay (ELISA). Biosci. Rep. 6, 895–900.
Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J & Rozen R (1996): Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7–9.
Johansson M, Witthöft CM, Bruce Å & Jägerstad M (2002): Study of wheat breakfast rolls fortified with folic acid. Eur. J. Nutr. 41, 279–286.
Kelly P, McPartlin J, Goggins M, Weir DG & Scott JM (1997): Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am. J. Clin. Nutr. 65, 1790–1795.
Konings EJM (1999): A validated liquid chromatographic method for determining folates in vegetables, milk powder, liver and flour. J. AOAC Int. 82, 119–127.
Lewis CJ, Crane NT, Wilson DB & Yetley EA (1999): Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am. J. Clin. Nutr. 70, 198–207.
Lucock M (2004): Is folic acid the ultimate functional food component for disease prevention? BMJ 328, 211–214.
Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B & Lin QR (1997): The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and metylenetetrahydrofolate reductase genotypes. Arterioscler. Thromb. Vasc. Biol. 17, 1157–1162.
MRC Vitamin Study Research Group (1991): Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338, 131–137.
O'Keefe CA, Bailey LB, Thomas EA, Hofler SA, Davis BA, Cerda JJ & Gregory JF (1995): Controlled dietary folate affects folate status in nonpregnant women. J. Nutr. 125, 2717–2725.
Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RCP, Alvarez JO, Macaluso M, Acton RT, Copeland RB, Cousins AL, Gore TB, Cornwell PE & Roseman JM (1994): Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am. J. Clin. Nutr. 59, 940–948.
Riddell LJ, Chisholm A, Williams S & Mann JI (2000): Dietary strategies for lowering homocysteine concentrations. Am. J. Clin. Nutr. 71, 1448–1454.
Rimm EB, Willett WC, Hu FB, Sampson L, Colditz AA, Manson JE, Hennekens C & Stampfer MJ (1998): Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279, 359–364.
Said HM, Horne DW & Wagner C (1986): Effect of human milk folate binding protein on folate intestinal transport. Arch. Biochem. Biophys. 251, 114–120.
Salter D & Blakeborough P (1988): Influence of goat's-milk folate-binding protein on transport of 5-methyltetrahydrofolate in neonatal-goat small intestinal brush-border-membrane vesicles. Br. J. Nutr. 59, 497–507.
Salter DN, Scott JK, Slade H & Andrews P (1981): The preparation and properties of folate-binding protein from cow's milk. Biochem. J. 193, 469–476.
Schorah CJ, Devitt H, Lucock M & Dowell AC (1998): The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study. Eur. J. Clin. Nutr. 52, 407–411.
Selhub J, Jacques PF, Wilson PWF, Rush D & Rosenberg IH (1993): Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270, 2693–2698.
Smith AM, Picciano MF & Deering RH (1985): Folate intake and blood concentrations of term infants. Am. J. Clin. Nutr. 41, 590–598.
Steinberg SE, Fonda S, Campbell CL & Hillman RS (1983): Cellular abnormalities of folate deficiency. Br. J. Haematol. 54, 605–612.
Strålsjö L, Arkbåge K, Witthöft CM & Jägerstad M (2002): Evaluation of a radioprotein-binding assay (RPBA) for folate analysis in berries and milk. Food Chem. 79, 525–534.
Tani M, Fushiki T & Iwai K (1983): Influence of folate binding protein from bovine milk on the absorption of folate in gastrointestinal tract of rat. Biochem. Biophys. Acta 757, 274–281.
Ubbink JB, Vermaak WJH & Bissbort S (1991): Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr. 565, 441–446.
Van Oort FVA, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB & Verhoef P (2003): Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose–response study. Am. J. Clin. Nutr. 77, 1318–1323.
Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH & Willett WC (1996): Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am. J. Epidemiol. 143, 845–859.
Verwei M, Arkbåge K, Havenaar R, van den Berg H, Witthöft C & Schaafsma G (2003): Folic acid and 5-methyltetrahydrofolate in fortified milk are bioaccessible as determined in a dynamic in vitro gastrointestinal model. J. Nutr. 133, 2377–2383.
Verwei M, van den Berg H, Havenaar R & Groten JP (2004): Effect of folate-binding protein on intestinal transport of folic acid and 5-methyltetrahydrofolate across Caco-2 cells. Eur. J. Nutr. (Epub, ahead of print).
Voedingsraad (1992): Nederlandse voedingsnormen (Dutch Nutrition Guidelines, language: Dutch). The Hague: Voorlichtingsbureau voor de Voeding.
Wagner C (1985): Folate binding proteins. Nutr. Rev. 43, 293–299.
Wigertz K, Hallmans G, Sandberg A-S, Tidehag P & Jägerstad MI (1997): Improved apparent dietary folate absorption in ileostomy subjects with the incorporation of milk into a mixed diet. In Characterisation and Availability. Thesis eds Wigertz K, Milk folates, pp 2–19. Lund: Lund University.
Wigertz K, Hansen I, Høier-Madsen M, Holm J & Jägerstad MI (1996): Effect of milk processing on the concentration of folate-binding protein (FBP), folate-binding capacity and retention of 5-methyltetrahydrofolate. Int. J. Food Sci. Nutr. 47, 315–322.
Williams S (ed) (1984): Microbiological assays. Official Methods of Analysis of the Association of Official Analytical Chemist 14th Edition. Arlington, VA, USA: AOAC Inc, 862–873.
Acknowledgements
This work was supported by the European Commission under the Framework 5 Programme: Key Action 1 – Food, Nutrition and Health; ‘Folate – from food to functionality and optimal health’ (QLK1-1999-00576); and Campina (Zaltbommel, The Netherlands). We thank Gertjan Schaafsma (TNO Nutrition and Food Research) for his advice and Frank Elbers and Jan Steijns (Campina Centre of Expertise Nutrition, Wageningen, The Netherlands) for developing and supplying the milk products. We thank the participants for their cooperation; the late Peter van de Bovenkamp for his analytical advice; Tineke van Roekel, Truus Kosmeijer and Jan Harryvan (Wageningen University), Karin Arkbåge (Swedish Agricultural University, Uppsala, Sweden), Hans Mocking (TNO Nutrition and Food Research, Zeist, The Netherlands) and Susanna Kariluoto (University of Helsinki, Helsinki, Finland) for carrying out the analyses; and Jan Burema and Hans Verhoef for their statistical advice.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guarantor: M Verwei.
Contributors: The study was designed by HvdB, JJMC and CEW. The practical work was prepared by JJMC, carried out by RJdJ with the assistance of MV, and supervised by CEW. ES was involved in the dietary aspects of the trial. RJdJ carried out the data analysis with assistance of CEW, JJMC and TvV. All authors contributed to the final version of the manuscript.
Rights and permissions
About this article
Cite this article
de Jong, R., Verwei, M., West, C. et al. Bioavailability of folic acid from fortified pasteurised and UHT-treated milk in humans. Eur J Clin Nutr 59, 906–913 (2005). https://doi.org/10.1038/sj.ejcn.1602159
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602159
Keywords
This article is cited by
-
In vitro bioaccessibility of added folic acid in commercially available baby foods formulated with milk and milk products
Food Science and Biotechnology (2019)
-
Plasma folate concentrations after a single dose ingestion of whole and skimmed folic acid fortified milks in healthy subjects
European Journal of Nutrition (2011)
-
A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk
European Journal of Nutrition (2009)
-
Bioavailability of vitamins A and E from whole and vitamin-fortified milks in control subjects
European Journal of Nutrition (2006)